| Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment CH Lee, YB Lee, MA Kim, H Jang, H Oh, SW Kim, EJ Cho, KH Lee, ... Clinical and Molecular Hepatology 26 (3), 328, 2020 | 38 | 2020 |
| Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis H Jang, YB Lee, H Moon, JW Chung, JY Nam, EJ Cho, JH Lee, SJ Yu, ... Hepatology 76 (2), 492-501, 2022 | 32 | 2022 |
| Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study JH Moon, S Jeong, H Jang, BK Koo, W Kim EClinicalMedicine 65, 2023 | 26 | 2023 |
| Empirical treatment with carbapenem vs third-generation cephalosporin for treatment of spontaneous bacterial peritonitis SW Kim, JS Yoon, J Park, YJ Jung, JS Lee, J Song, HA Lee, YS Seo, ... Clinical Gastroenterology and Hepatology 19 (5), 976-986. e5, 2021 | 23 | 2021 |
| Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response JE Na, DH Sinn, JH Lee, HJ Jang, SY Baek, KA Kim, WS Kang, GY Gwak, ... Journal of Viral Hepatitis 28 (10), 1392-1399, 2021 | 15 | 2021 |
| Yttrium-90 radioembolization is associated with better clinical outcomes in patients with hepatocellular carcinoma compared with conventional chemoembolization: a propensity … MA Kim, H Jang, NR Choi, JY Nam, YB Lee, EJ Cho, JH Lee, SJ Yu, ... Journal of Hepatocellular Carcinoma, 1565-1577, 2021 | 12 | 2021 |
| Impact of HBeAg on hepatocellular carcinoma risk during oral antiviral treatment in patients with chronic hepatitis B H Jang, JS Yoon, SY Park, HA Lee, M Jang, SU Kim, DH Sinn, YS Seo, ... Clinical Gastroenterology and Hepatology 20 (6), 1343-1353. e16, 2022 | 11 | 2022 |
| Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease H Jang, Y Kim, DH Lee, SK Joo, BK Koo, S Lim, W Lee, W Kim JAMA Internal Medicine 184 (4), 375-383, 2024 | 10 | 2024 |
| Effectiveness of lenvatinib versus sorafenib for unresectable hepatocellular carcinoma in patients with hepatic decompensation MK Park, YB Lee, H Moon, NR Choi, MA Kim, H Jang, JY Nam, EJ Cho, ... Digestive Diseases and Sciences 67 (10), 4939-4949, 2022 | 9 | 2022 |
| Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors? H Jang, W Kim Clinical and Molecular Hepatology 29 (2), 381, 2023 | 5 | 2023 |
| Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease H Jang, KW Joo, SS Han Kidney Research and Clinical Practice 38 (2), 250, 2019 | 5 | 2019 |
| Heart rate is associated with mortality in patients undergoing continuous renal replacement therapy S Lee, Y Lee, H Jang, H Moon, DK Kim, SS Han Kidney research and clinical practice 36 (3), 250, 2017 | 5 | 2017 |
| Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD YK Lee, BK Koo, SK Joo, DH Lee, H Jang, JW Chai, MS Lee, SW Jang, ... Alimentary Pharmacology & Therapeutics 58 (3), 322-333, 2023 | 3 | 2023 |
| A sequential approach using the age‐adjusted fibrosis‐4 index and vibration‐controlled transient elastography to detect advanced fibrosis in Korean patients with non‐alcoholic … DH Lee, SU Sung, YK Lee, IH Lim, H Jang, SK Joo, JH Park, MS Chang, ... Alimentary Pharmacology & Therapeutics 55 (8), 994-1007, 2022 | 3 | 2022 |
| Pnpla3 Genotypes modify the adverse effect of the total energy intake on high-risk Nonalcoholic Steatohepatitis development H Son, BK Koo, SK Joo, DH Lee, H Jang, JH Park, MS Chang, W Kim The American Journal of Clinical Nutrition 117 (5), 910-917, 2023 | 2 | 2023 |
| Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatotic liver disease with increased alcohol intake increase the risk of … GA Kim, S Jeong, H Jang, DH Lee, SK Joo, W Kim Liver Cancer, 2023 | 2 | 2023 |
| Effectiveness of transarterial chemoembolization-first treatment for advanced hepatocellular carcinoma: A propensity score matching analysis SW Chung, MK Park, YY Cho, Y Park, CH Lee, H Oh, H Jang, MA Kim, ... Journal of Hepatocellular Carcinoma, 587-598, 2021 | 2 | 2021 |
| Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: a nationwide cohort study MH Hur, DH Lee, JH Lee, MS Kim, J Park, H Shin, SW Chung, HJ Cho, ... Clinical and Molecular Hepatology, 2024 | 1 | 2024 |
| Regorafenib versus nivolumab for hepatocellular carcinoma patients who experienced sorafenib treatment failure: A propensity score analysis CH Lee, YB Lee, MA Kim, H Jang, SW Kim, EJ Cho, JH Lee, SJ Yu, ... Hepatology 70, 212A-213A, 2019 | 1 | 2019 |
| WED-260 Comparative analysis of Agile 3+, NFS, and BARD scores for diagnosing advanced fibrosis in MASLD and MetALD D Lee, YK Lee, H Jang, S Joo, W Kim, YH So, YJ Jung Journal of Hepatology 80, S532, 2024 | | 2024 |
Su Jong YuSeoul National University Hospital在 snu.ac.kr 的电子邮件经过验证
